Treatment of acute salpingitis with sulbactam/ampicillin
- PMID: 2529873
- DOI: 10.1016/0020-7292(89)90091-x
Treatment of acute salpingitis with sulbactam/ampicillin
Abstract
The combination of sulbactam/ampicillin was compared to cefoxitin for the treatment of acute salpingitis in 40 women divided into two groups of 20 women each. There were 11 patients in each group who were given doxycycline because of evidence of chlamydial infection. All patients were diagnosed by laparoscopic examination and evaluated by the same procedure 7-12 weeks later. At the second laparoscopy, only 1 of the 20 patients (5%) treated with sulbactam/ampicillin had severe adhesions, while 6 of the 20 patients (40%) treated with cefoxitin had severe adhesions. Tubal patency was without obstruction in 14 patients (70%) given the combination treatment and in 12 patients (60%) given cefoxitin. Side effects were essentially absent in both groups.
Similar articles
-
[Acute bacterial salpingitis. The importance of residual inflammation. A comparative study with celioscopic control of 2 antibiotic protocols: sulbactam-ampicillin versus cefoxitin].J Gynecol Obstet Biol Reprod (Paris). 1990;19(6):765-72. J Gynecol Obstet Biol Reprod (Paris). 1990. PMID: 2147930 Clinical Trial. French.
-
Treatment of acute salpingitis with sulbactam/ampicillin. Comparison with cefoxitin.Drugs. 1986;31 Suppl 2:7-10. doi: 10.2165/00003495-198600312-00002. Drugs. 1986. PMID: 3013571 Clinical Trial.
-
Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.Antimicrob Agents Chemother. 1991 Aug;35(8):1651-6. doi: 10.1128/AAC.35.8.1651. Antimicrob Agents Chemother. 1991. PMID: 1929337 Free PMC article. Clinical Trial.
-
Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infection.Am J Med Sci. 1991 Jun;301(6):406-11. doi: 10.1097/00000441-199106000-00011. Am J Med Sci. 1991. PMID: 2039029 Review. No abstract available.
-
[New specialty drugs registered in Austria. Unasyn].Wien Klin Wochenschr. 1989 Nov 10;101(21):754-60. Wien Klin Wochenschr. 1989. PMID: 2686180 Review. German. No abstract available.
Cited by
-
Ampicillin/sulbactam: current status in severe bacterial infections.Drugs. 2007;67(13):1829-49. doi: 10.2165/00003495-200767130-00003. Drugs. 2007. PMID: 17722953 Review.
-
Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?Am J Obstet Gynecol. 2008 Jan;198(1):30.e1-7. doi: 10.1016/j.ajog.2007.05.021. Am J Obstet Gynecol. 2008. PMID: 18166300 Free PMC article. Clinical Trial.
-
Antibiotic therapy for pelvic inflammatory disease.Cochrane Database Syst Rev. 2020 Aug 20;8(8):CD010285. doi: 10.1002/14651858.CD010285.pub3. Cochrane Database Syst Rev. 2020. PMID: 32820536 Free PMC article.
-
Antibiotic therapy for pelvic inflammatory disease.Cochrane Database Syst Rev. 2017 Apr 24;4(4):CD010285. doi: 10.1002/14651858.CD010285.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 20;8:CD010285. doi: 10.1002/14651858.CD010285.pub3. PMID: 28436019 Free PMC article. Updated.